News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Lea Monteran: TIGIT blockade with MDSC inhibition may be a novel and promising therapeutic strategy to treat bone metastasis
Photo taken from Lea Monteran/X
Mar 8, 2024, 19:03

Lea Monteran: TIGIT blockade with MDSC inhibition may be a novel and promising therapeutic strategy to treat bone metastasis

Lea Monteran, Ph.D. student at Tel Aviv University, shared on X/Twitter:

“I am excited to share our latest work (and Ph.D.’s baby) with Neta Erez on breast cancer bone metastasis, showing how combining TIGIT blockade with MDSC inhibition may be a novel and promising therapeutic strategy to treat bone metastasis. In Cancer Discovery.”

Lea Monteran: TIGIT blockade with MDSC inhibition may be a novel and promising therapeutic strategy to treat bone metastasis

Proceed to the article.
Source: Lea Monteran/X

bone metastases Breast Cancer cancer Cancer Discovery Lea Monteran MDSC inhibition metastatic breast cancer Neta Erez OncoDaily Oncology Tel Aviv University TIGIT blockade
Special Coverage
Blog
Nov 13, 2024, 10:06
A first-in-class Antibody Drug Conjugate that works by directly stimulating the immune system
Blog
Nov 13, 2024, 09:55
Moderna Incorporation announced the awardees of its 2024 Australia Fellowship Program
Blog
Nov 13, 2024, 09:39
AI tools to improve diagnosis and therapy in neuro-oncology
Insight
Nov 13, 2024, 09:27
Nikki Rossetti et al. on Early-Stage Lung Cancer in the Era of Lung Cancer Screening
Blog
Nov 13, 2024, 09:14
Yüksel Ürün: Key takeaways on high-risk and locally advanced prostate cancer from António Rui Azevedo Freitas
Blog
Nov 13, 2024, 09:11
Clinical outcomes of early-stage triple-negative breast cancer after neoadjuvant chemotherapy
Blog
Nov 13, 2024, 09:09
Yüksel Ürün: Not all that shines is Prostate cancer – a striking reminder from Daniela Oprea-Lager
Blog
Nov 13, 2024, 09:01
Updated Results with Mitazalimab as a first-line treatment for advance pancreatic cancer
Blog
Nov 13, 2024, 08:59
Miriam Mutebi: What To Expect During A Mammogram
Insight
Nov 13, 2024, 08:56
Rachel Riechelmann: Low dose Everolimus for patients with Neuroendocrine tumors
Insight
Nov 13, 2024, 08:51
Reporting pharmacogenetic variants and cancer WGS data could guide safer prescribing
Blog
Nov 13, 2024, 08:49
Yüksel Ürün: Promising findings on SGLT2 as a biomarker for papillary RCC by Erman Akkus